Cannabis and Tolerance: Acute Drug Impairment As a Function of Cannabis Use History

Overview

Journal Sci Rep

Specialty Science

Date 2016 May 27

PMID 27225696

Citations 26

Authors

J G Ramaekers

J H van Wel

D B Spronk

S W Toennes

K P C Kuypers

E L Theunissen

R J Verkes

Affiliations

Soon will be listed here.

Abstract

Cannabis use history as predictor of neurocognitive response to cannabis intoxication remains subject to scientific and policy debates. The present study assessed the influence of cannabis on neurocognition in cannabis users whose cannabis use history ranged from infrequent to daily use. Drug users (N = 122) received acute doses of cannabis (300 μg/kg THC), cocaine HCl (300 mg) and placebo. Cocaine served as active control for demonstrating neurocognitive test sensitivity. Executive function, impulse control, attention, psychomotor function and subjective intoxication were significantly worse after cannabis administration relative to placebo. Cocaine improved psychomotor function and attention, impaired impulse control and increased feelings of intoxication. Acute effects of cannabis and cocaine on neurocognitive performance were similar across cannabis users irrespective of their cannabis use history. Absence of tolerance implies that that frequent cannabis use and intoxication can be expected to interfere with neurocognitive performance in many daily environments such as school, work or traffic.

Citing Articles

Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.

Ramaekers J, Reckweg J, Mason N, Kuypers K, Toennes S, Theunissen E Neuropsychopharmacology. 2024; .

PMID: 39719487 DOI: 10.1038/s41386-024-02042-7.

An observational study of clinical outcome measures in patients treated with cannabis-based medicinal products on the UK Medical Cannabis Registry.

Erridge S, Leung O, Holvey C, Coomber R, Beri S, Khan S Neuropsychopharmacol Rep. 2023; 43(4):616-632.

PMID: 38057993 PMC: 10739137. DOI: 10.1002/npr2.12403.

Cannabis Use Among U.S. Military Veterans Following Residential Substance Use Disorder Treatment.

Mian M, Chan Osilla K, Blonigen D Mil Med. 2023; 188(11-12):e3591-e3598.

PMID: 37294846 PMC: 10629989. DOI: 10.1093/milmed/usad216.

Vaporized Delta-9-tetrahydrocannabinol Inhalation in Female Sprague Dawley Rats: A Pharmacokinetic and Behavioral Assessment.

Penman S, Berthold E, Mihalkovic A, Hammond N, McCurdy C, Blum K Curr Pharm Des. 2023; 29(27):2149-2160.

PMID: 37114788 PMC: 10979821. DOI: 10.2174/1381612829666230419093809.

Trends and outcomes of trauma patients positive to marijuana and cocaine.

Roque-Torres J, Ramirez-Martinez L, Ramos-Melendez E, Garcia-Rodriguez O, Rodriguez-Lopez A, Guerrios L Eur J Trauma Emerg Surg. 2023; 49(4):1969-1979.

PMID: 37000193 PMC: 10449943. DOI: 10.1007/s00068-023-02261-5.

References

Desrosiers N, Ramaekers J, Chauchard E, Gorelick D, Huestis M . Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. J Anal Toxicol. 2015; 39(4):251-61. PMC: 4416120. DOI: 10.1093/jat/bkv012. View

Spronk D, van Wel J, Ramaekers J, Verkes R . Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev. 2013; 37(8):1838-59. DOI: 10.1016/j.neubiorev.2013.07.003. View

Metrik J, Kahler C, Reynolds B, McGeary J, Monti P, Haney M . Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl). 2012; 223(4):489-99. PMC: 3829473. DOI: 10.1007/s00213-012-2740-y. View

Vadhan N, Hart C, van Gorp W, Gunderson E, Haney M, Foltin R . Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol. 2007; 29(4):357-64. DOI: 10.1080/13803390600693615. View

Hart C, Ilan A, Gevins A, Gunderson E, Role K, Colley J . Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav. 2010; 96(3):333-41. PMC: 5858872. DOI: 10.1016/j.pbb.2010.06.003. View

Hartman R, Huestis M . Cannabis effects on driving skills. Clin Chem. 2012; 59(3):478-92. PMC: 3836260. DOI: 10.1373/clinchem.2012.194381. View

Schwope D, Bosker W, Ramaekers J, Gorelick D, Huestis M . Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. J Anal Toxicol. 2012; 36(6):405-12. PMC: 3523952. DOI: 10.1093/jat/bks044. View

Nowlan R, Cohen S . Tolerance to marijuana: heart rate and subjective "high". Clin Pharmacol Ther. 1977; 22(5 Pt 1):550-6. DOI: 10.1002/cpt1977225part1550. View

Hart C, Van Gorp W, Haney M, Foltin R, FISCHMAN M . Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology. 2001; 25(5):757-65. DOI: 10.1016/S0893-133X(01)00273-1. View

10.

Curran H, Brignell C, Fletcher S, Middleton P, Henry J . Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl). 2002; 164(1):61-70. DOI: 10.1007/s00213-002-1169-0. View

11.

Gonzalez R . Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance. Neuropsychol Rev. 2007; 17(3):347-61. DOI: 10.1007/s11065-007-9036-8. View

12.

van Wel J, Kuypers K, Theunissen E, Toennes S, Spronk D, Verkes R . Single doses of THC and cocaine decrease proficiency of impulse control in heavy cannabis users. Br J Pharmacol. 2013; 170(7):1410-20. PMC: 3838687. DOI: 10.1111/bph.12425. View

13.

Toennes S, Ramaekers J, Theunissen E, Moeller M, Kauert G . Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol. 2008; 32(7):470-7. DOI: 10.1093/jat/32.7.470. View

14.

Ramaekers J, Berghaus G, van Laar M, Drummer O . Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004; 73(2):109-19. DOI: 10.1016/j.drugalcdep.2003.10.008. View

15.

Jex H, McDonnell J, Phatak A . A "critical" tracking task for man-machine research related to the operator's effective delay time. I. Theory and experiments with a first-order divergent controlled element. NASA CR-616. NASA Contract Rep NASA CR. 1966; :1-105. View

16.

Hall W, Degenhardt L . Adverse health effects of non-medical cannabis use. Lancet. 2009; 374(9698):1383-91. DOI: 10.1016/S0140-6736(09)61037-0. View

17.

Crane N, Schuster R, Fusar-Poli P, Gonzalez R . Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev. 2012; 23(2):117-37. PMC: 3593817. DOI: 10.1007/s11065-012-9222-1. View

18.

Logan G, Cowan W, Davis K . On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol Hum Percept Perform. 1984; 10(2):276-91. DOI: 10.1037//0096-1523.10.2.276. View

19.

Hall W . What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?. Addiction. 2014; 110(1):19-35. DOI: 10.1111/add.12703. View

20.

Ramaekers J, Kauert G, van Ruitenbeek P, Theunissen E, Schneider E, Moeller M . High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology. 2006; 31(10):2296-303. DOI: 10.1038/sj.npp.1301068. View